As billions in taxpayer funds are funneled into foreign aid for Ukraine and Israel, the healthcare systems in both the United Kingdom and the United States are showing alarming signs of collapse. Reports from both sides of the Atlantic paint a grim picture of underfunded and mismanaged services, leaving citizens to bear the brunt of privatized profits and socialized losses.
In the UK, a recent report by the Royal College of Nursing has revealed the National Health Service (NHS) is nearing a breaking point. Overcrowded hospitals have forced nursing staff to care for patients in makeshift spaces such as corridors, storerooms, car parks, and even toilets. Vital equipment like oxygen and monitors is often unavailable, and some patients have been left to die in corridors, remaining undiscovered for hours.
The NHS’s deterioration follows decades of neoliberal reforms, starting with Tony Blair’s New Labour government, which privatized hospital construction and outsourced surgeries and diagnostics to the private sector. Even Labour’s current leader, Prime Minister Keir Starmer, has acknowledged the system’s failures, with his Secretary of State for Health, Wes Streeting, admitting last year that the NHS is “broken” and patients are “not receiving the care they deserve.”
Across the Atlantic, the situation in the United States is equally dire. Despite spending 18% of its GDP on healthcare—the highest of any developed nation—the US suffers from worse health outcomes, shorter life expectancy, and higher disease rates compared to peer nations.
UnitedHealth CEO Andrew Witty described the system as “complex” and “costly” this week, echoing widespread concerns. Over 26 million Americans remain uninsured, leaving households vulnerable to financial ruin from hospital or drug bills. A report from the Kaiser Family Foundation found the US spends $12,914 per capita on healthcare—double the expenditure of comparable countries—while administrative costs topped $1 trillion in 2023.
A separate Commonwealth Fund report attributed much of the excess spending to inefficiencies, including bloated administrative costs linked to insurance companies, hospital management, and high prescription drug prices.
